| Product Name | MF | CAS | Details |
|---|
| OMEPRAZOLE IMPURITY DOMEPRAZOLE SULPHONE EP STANDARD | C17H19N3O3S | Details |
| Canagliflozin | C24H25FO5S | 842133-18-0 | Details |
| Atorvastatin Calcium Impurity VI Degradation Product | C18H18FN3O6 | 151377-74-1 | Details |
| LY2835219 | C15H13ClF2N4 | 1231930-42-9 | Details |
| (S)-Cinacalcet hydrochloride | C22H23ClF3N | 1217809-88-5 | Details |
| OseltaMivir iMpurity E | C11H18N2O4 | 903907-74-4 | Details |
| Mycophenolate IMpurity | Details |
| Acebutolol EP Impurity D | Details |
| Diclofenac | Details |
| Quinapril IMpuriy | Details |
| Carfilzomib | C40H57N5O7 | 868540-17-4 | Details |
| AP26113 | C26H34ClN6O2P | 1197958-12-5 | Details |
| (3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan | C17H16ClIO2 | 915095-94-2 | Details |
| Nebivolol O-Beta-D-Glucuronide | 1698091-61-0 | Details |
| SalbutaMol IMpurity C | C13H21NO3 | Details |
| Sertraline IMpurity (SRTRC-3) | C17H17Cl2N | Details |
| Pantoprazole IMpurity (Mixture of IMpurity D and F) | Details |
| Pitavastatin IMpurity 4 (PP-4) | C25H22FNO3 | 1422058-54-5 | Details |
| Pregabalin IMpurity | C7H18N2 | 159029-27-3 | Details |
| 2',3'-Didehydro Lovastatin | Details |
| Group Doppler impurity | Details |
| Naltrexone hydrochloride impurity C | Details |
| CO-1686 | C11H16N2O2 | 68621-88-5 | Details |
| WZ8040 | C24H25ClN6OS | 1214265-57-2 | Details |
| CO-1686 | C27H28F3N7O3 | 1374640-70-6 | Details |
| Glimepiride impurity | C24H34N4O5S | Details |
| Nizatidine impurity | Details |
| Valaciclovir iMpurity | Details |
| J | C17H14Cl2F2N2O4 | 1026258-58-1 | Details |
| OMEPRAZOLE IMPURITY DOMEPRAZOLE SULPHONE EP STANDARD | C25H22F6N4O2S | 1083100-27-9 | Details |
| Sildenafil Aldehyde IMpurity | C17H22N4O2 | 845302-49-0 | Details |
| Canagliflozin | 2(C24H25FO5S).H2O | 928672-86-0 | Details |
| CO-1686 | C16H16ClF3N4O2 | 1374507-23-9 | Details |
| Alfuzosin impurity | Details |
| Diltiazem impurity | C17H18N2O3S | 115992-91-1 | Details |
| rac-3-Des[2-(dimethylamino)ethyl]-Zolmitriptan 3-Acetic Acid-d3 | C14H14N2O4 | 1432902-38-9 | Details |
| Raloxifene EP IMpurity | C13H15ClN2O2S | 1700655-64-6 | Details |
| Rabeprazole iMpurity (Chloro interMediate | C18H21N3O3S | 117976-89-3 | Details |
| 1,2,3-Trithiane-4-pentanoic Acid | C8H14O2S3 | 1204245-29-3 | Details |
| Perindopril Impurity | Details |
| TranexaMic Acid iMpurity | C8H15NO2 | Details |
| Meloxicam impurity | Details |
| Sumatriptan | C14H21N3O2S | Details |
| WZ4002 | C25H27ClN6O3 | 1213269-23-8 | Details |
| EMpagliflozin | C23H27ClO7 | 864070-44-0 | Details |
| SalMeterol IMpurity | C25H37NO4 | 144391-74-2 | Details |
| Montelukast iMpurity | Details |
| Methotrexate impurity | Details |
| Paliperidone impurity | Details |
| 2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene | C18H14FIS | 898566-17-1 | Details |
| COLURACETAM | C19H23N3O3 | 135463-81-9 | Details |
| Methyl 2,3,4-trifluoro-5-nitrobenzoate | C8H4F3NO4 | 918321-24-1 | Details |
| Pioglitazone BroMo IMpurity | Details |
| Vortioxetine | C18H22N2S | 508233-74-7 | Details |
| ABT-199 | C45H50ClN7O7S | 1257044-40-8 | Details |
| (2S)-2-Amino-4-methyl-1-((2R)-2-methyloxiranyl)-1-pentanone Trifluoroacetate | C9H17NO2.C2HF3O2 | 247068-85-5 | Details |
| CO-1686 | C13H19N3O2 | 1021426-42-5 | Details |
| (E)-3α-hydroxy-6-ethylidene-7-keto-5β-cholan-24-oic acid | C26H40O4 | 1516887-33-4 | Details |
| Ampicillin impurity | Details |
| DONEPEZIL IMP | C24H22NO4.Cl | 923571-16-8 | Details |
| Zolpidem | C17H17N3O | 365213-58-7 | Details |
| TaMsulosin EP IMpurity | C20H28N2O5S | 1798904-07-0 | Details |
| Stugeron | C26H28N2 | 298-57-7 | Details |
| REPAGLINIDE RELATED COMPOUND C (25 MG) ((S)-2-ETHOXY-4-[2-[[2-PHENYL-1 -[2-(1 -PIPERIDINYL)PHE-NYL]ETHYL]AMINO]-2-OXOETHYL] BENZOIC ACID) | C30H34N2O4 | 107362-12-9 | Details |
| (S)-(+)-2-Chlorophenylglycine methyl ester | C9H10ClNO2 | 141109-14-0 | Details |
| LY2835219 | C12H20N4 | 1180132-17-5 | Details |
| 2-(5-BroMo-2-Methylbenzyl)-5-(4-fluorophenyl)thiophene | C18H14BrFS | 1030825-20-7 | Details |
| Vortioxetine (Lu AA21004) HBr | C18H23BrN2S | 960203-27-4 | Details |
| LY2835219 | C27H32F2N8 | 1231929-97-7 | Details |
| Oxaliplatin impurity | Details |
| Diacerein impurity | Details |
| NiMesulide EP IMpurity | C7H8N2O5S | 38880-53-4 | Details |
| 4-Amino-3-chlorophenol hydrochloride | C6H7Cl2NO | 52671-64-4 | Details |
| WZ3146 | C24H25ClN6O2 | 1214265-56-1 | Details |
| Rucaparib | C19H21FN3O5P | 459868-92-9 | Details |
| Edoxaban | C31H38ClN7O7S2 | 1229194-11-9 | Details |
| Rosuvastatin IMpurity (5-Oxo Rosuvastatin tert-Butyl Ester) | C22H28FN3O6S | 854898-53-6 | Details |
| Quetiapine IMpurity [2-(2-Piperazin-1-yl)ethoxy)ethanol] | C25H18N2S2 | 2206135-50-2 | Details |
| Ondansetron IMpurity | Details |
| Empagliflozin Impurity | C21H25ClO8 | 2253771-11-6 | Details |
| Ramipril impurity | C23H32N2O5 | Details |
| Naltrexone hydrochloride impurity A | Details |
| Ciprofloxacin impurity | C17H18FN3O3 | Details |
| Pravastatin iMpurity (6a-OH-iso-coMpactin OH acid) | C23H36O7 | Details |
| Dioxin impurity | C4H4O2 | Details |
| Entecavir Impurity | C12H15N5O3 | 1333204-94-6 | Details |
| Naltrexone hydrochloride impurity B | Details |
| Rivastigmine | C14H22N2O2 | 123441-03-2 | Details |
| TOPOTECANACETATE | C25H27N3O7 | 123948-88-9 | Details |
| LY2835219 | C11H12BrFN2 | 1231930-33-8 | Details |
| O-Isobutyryl (R)-Fesoterodine | C30H43NO4 | 1208313-13-6 | Details |
| LY2835219 | C17H24BFN2O2 | 1231930-37-2 | Details |
| Mirtazapine iMpurity | C16H17N3 | 1188331-80-7 | Details |
| Sitagliptin iMpurity | C16H12F6N4O | 1675201-14-5 | Details |
| Paroxetine IMpurity | Details |
| PiroxicaM IMpurity ( N-(2-Pyridinyl)oxaMic Acid ) | Details |
| (4R,5S)-4,5-Dichloro-4,5-dimethyl-1,3-dioxolan-2-one | C5H6Cl2O3 | 116857-04-6 | Details |
| Entacapone | Details |
| nifedipine iMpurity | C19H22N2O6 | Details |
| TICARCILLIN IMPURITY | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 | ||||